JP2022527080A5 - - Google Patents
Info
- Publication number
- JP2022527080A5 JP2022527080A5 JP2021557368A JP2021557368A JP2022527080A5 JP 2022527080 A5 JP2022527080 A5 JP 2022527080A5 JP 2021557368 A JP2021557368 A JP 2021557368A JP 2021557368 A JP2021557368 A JP 2021557368A JP 2022527080 A5 JP2022527080 A5 JP 2022527080A5
- Authority
- JP
- Japan
- Prior art keywords
- methanone
- imidazole
- piperidine
- phenyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962825051P | 2019-03-28 | 2019-03-28 | |
| US62/825,051 | 2019-03-28 | ||
| PCT/US2020/024969 WO2020198478A1 (en) | 2019-03-28 | 2020-03-26 | Serotonin 5-ht2b inhibitory compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022527080A JP2022527080A (ja) | 2022-05-30 |
| JP2022527080A5 true JP2022527080A5 (https=) | 2022-10-25 |
| JP7454589B2 JP7454589B2 (ja) | 2024-03-22 |
Family
ID=70775466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557368A Active JP7454589B2 (ja) | 2019-03-28 | 2020-03-26 | セロトニン５－ｈｔ２ｂ阻害化合物 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US12240827B2 (https=) |
| EP (1) | EP3947360B1 (https=) |
| JP (1) | JP7454589B2 (https=) |
| CN (1) | CN113631548B (https=) |
| AU (1) | AU2020245614B2 (https=) |
| BR (1) | BR112021019314A2 (https=) |
| CA (1) | CA3134952C (https=) |
| DK (1) | DK3947360T3 (https=) |
| ES (1) | ES2991167T3 (https=) |
| FI (1) | FI3947360T3 (https=) |
| PL (1) | PL3947360T3 (https=) |
| PT (1) | PT3947360T (https=) |
| WO (1) | WO2020198478A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240027076A (ko) * | 2021-07-26 | 2024-02-29 | 조에티스 서비시즈 엘엘씨 | 세로토닌 5-ht2b 억제 화합물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0515995D0 (en) | 2005-08-03 | 2005-09-07 | Sandoz Ag | Organic compounds |
| WO2007097197A1 (ja) * | 2006-02-20 | 2007-08-30 | Astellas Pharma Inc. | アミド誘導体またはその塩 |
| TWI415845B (zh) | 2006-10-03 | 2013-11-21 | Arena Pharm Inc | 用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物 |
| JP2012512877A (ja) * | 2008-12-18 | 2012-06-07 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | セロトニン５−ｈｔ２ｂ受容体阻害剤 |
| US8697739B2 (en) | 2010-07-29 | 2014-04-15 | Novartis Ag | Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof |
-
2020
- 2020-03-26 PL PL20726982.0T patent/PL3947360T3/pl unknown
- 2020-03-26 US US17/441,340 patent/US12240827B2/en active Active
- 2020-03-26 EP EP20726982.0A patent/EP3947360B1/en active Active
- 2020-03-26 JP JP2021557368A patent/JP7454589B2/ja active Active
- 2020-03-26 PT PT207269820T patent/PT3947360T/pt unknown
- 2020-03-26 ES ES20726982T patent/ES2991167T3/es active Active
- 2020-03-26 FI FIEP20726982.0T patent/FI3947360T3/fi active
- 2020-03-26 WO PCT/US2020/024969 patent/WO2020198478A1/en not_active Ceased
- 2020-03-26 AU AU2020245614A patent/AU2020245614B2/en active Active
- 2020-03-26 CN CN202080024800.0A patent/CN113631548B/zh active Active
- 2020-03-26 DK DK20726982.0T patent/DK3947360T3/da active
- 2020-03-26 BR BR112021019314A patent/BR112021019314A2/pt unknown
- 2020-03-26 CA CA3134952A patent/CA3134952C/en active Active
-
2025
- 2025-01-21 US US19/032,924 patent/US20250179046A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2646483C2 (ru) | Твердые фармацевтические композиции для перорального введения на основе изоксазолиновых соединений | |
| JP4854511B2 (ja) | 糖尿病治療剤 | |
| HRP20250386T1 (hr) | Derivati piperidinil-indola za upotrebu u liječenju c3 glomerulopatije | |
| ES2225199T3 (es) | Uso de ligandos del receptor ep4 en el tratamiento del dolor neuropatico. | |
| JP2004503501A5 (https=) | ||
| HRP20090593T1 (hr) | Derivati benzimidazola i njihova uporaba kao antagonista aii receptora | |
| JP2012505836A5 (https=) | ||
| ES2437072T3 (es) | Preparación sólida | |
| JP2016512825A5 (https=) | ||
| RU2007120454A (ru) | Производные хинуклидина и их применение в качестве антагонистов мускариновых рецепторов м3 | |
| RU2007140737A (ru) | Пиразолы | |
| NZ592748A (en) | 2-Amino-(oxadiazol-3-yl)-benzofuran derivatives and their use as S1P receptor modulators | |
| SI2315587T1 (en) | A therapeutic composition comprising macitentan | |
| RU2015121044A (ru) | Производные фенилэтилпиридина в качестве ингибиторов pde4 | |
| RU2016121854A (ru) | Производные гетероарила | |
| RU2015121043A (ru) | Производные фенилэтилпиридина в качестве ингибиторов PDE-4 | |
| JP2003518106A5 (https=) | ||
| RU2006134022A (ru) | Производные индазола и содержащие их фармацевтические композиции | |
| JP2022527080A5 (https=) | ||
| JP2009517411A5 (https=) | ||
| RU2311408C2 (ru) | Производные аминотетралина в качестве антагонистов мускаринового рецептора | |
| JP2011518843A5 (https=) | ||
| RU2011105463A (ru) | ФАРМАЦЕВТИЧЕСКИЙ ПРОДУКТ, СОДЕРЖАЩИЙ АНТАГОНИСТ МУСКАРИНОВОГО РЕЦЕПТОРА И АГОНИСТ β2-АДРЕНОРЕЦЕПТОРА | |
| TWI439269B (zh) | ４－環丙基甲氧基－ｎ－（３，５－二氯－１－氧離子基吡啶－４－基）－５－（甲氧基）吡啶－２－甲醯胺於製備用於治療與帕金森氏病有關之運動障礙症的藥物之用途 | |
| DE60013751D1 (de) | Optisch aktive 3-((2-piperazinyl-phenyl)methyl)-1-(4-(trifluoromethyl)-phenyl)-2-pyrrolidinone als selektive 5-HT1D Rezeptor Antagonisten |